Mechanisms of action of ECT in Parkinson's disease: possible role of pineal melatonin.
Recent clinical studies have suggested that electroconvulsive therapy (ECT) may be efficacious in the therapy of Parkinson's disease (PD). However, the mechanisms of action of ECT in PD are largely unknown. PD may be associated with reduction in the secretory activity of pineal melatonin, and the therapeutic efficacy of ECT in PD may be associated with an effect on the secretory activity of pineal melatonin. Further studies involving analysis of plasma melatonin levels and circadian release prior to and following ECT are needed more precisely to determine the role of pineal melatonin in PD and in the therapeutic efficacy of ETC in PD.
Sandyk
R
R
Department of Clinical Neuropsychiatry, New York State Psychiatric Institute, NY 10032.
D004565:Electroconvulsive Therapy; D006801:Humans; D008550:Melatonin / Q000502:physiology*; D010300:Parkinson Disease / Q000503:physiopathology / Q000628:therapy*; D010870:Pineal Gland / Q000503:physiopathology*
D008550:Melatonin